Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Tao Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6643-4686; OpenAlex author ID A5100375710. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 6

  1. Clinicopathological Characteristics, Prognosis, and Correlated Tumor Cell Function of Tropomodulin-3 in Pancreatic Adenocarcinoma. Co-author DOI 10.2174/1386207326666230810142646↗
  2. Ribonucleotide reductase M2 subunit silencing suppresses tumorigenesis in pancreatic cancer via inactivation of PI3K/AKT/mTOR pathway. Co-author DOI 10.1016/j.pan.2022.03.002↗
  3. Study of underlying pancreatic cancer could be improved. First author DOI 10.1016/j.hpb.2019.12.015↗
  4. Prognostic significance of tissue factor in patients with pancreatic cancer: a systematic review protocol. Co-author DOI 10.1136/bmjopen-2020-037431↗
  5. Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization. Co-author DOI 10.3892/ol.2017.6836↗
  6. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer. Co-author DOI 10.4103/0366-6999.201613↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bin Zhong · 1 shared paper, 2024 · strength 0.23
  2. Jianxin Zhang · 1 shared paper, 2024 · strength 0.23
  3. Weidong Jin · 1 shared paper, 2024 · strength 0.23
  4. Zhonghu Li · 1 shared paper, 2024 · strength 0.23
  5. Jinlan Shan · 1 shared paper, 2022 · strength 0.16
  6. Xiyong Liu · 1 shared paper, 2022 · strength 0.16
  7. Xiaochen Wang · 1 shared paper, 2022 · strength 0.16
  8. Zhen Wang · 1 shared paper, 2022 · strength 0.16
  9. Liang‐Hao Hu · 1 shared paper, 2020 · strength 0.15
  10. Liu Yu · 1 shared paper, 2020 · strength 0.15
  11. Zhao‐Shen Li · 1 shared paper, 2020 · strength 0.15
  12. Pengxian Tao · 1 shared paper, 2020 · strength 0.09
  13. Hao Chen · 1 shared paper, 2020 · strength 0.09
  14. Yang Yu · 1 shared paper, 2020 · strength 0.09
  15. Haiyuan Li · 1 shared paper, 2020 · strength 0.09
  16. Zizheng Wang · 1 shared paper, 2017 · strength 0.08
  17. Rong Liu · 1 shared paper, 2017 · strength 0.08
  18. Weihong Duan · 1 shared paper, 2017 · strength 0.07
  19. Tao Yan · 1 shared paper, 2017 · strength 0.07
  20. Wei Lv · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.